Stock Screener
US stocks rated by the Lician Quant model: a 1–5 rating and A+ to F grades for valuation, growth, profitability, momentum and EPS revisions, each against the stock’s sector. Filter, sort by any factor and share the URL.
68 stocks · Strong Buy · Healthcare
| Stock | Quant ratingRating | ValuationVal | GrowthGrow | ProfitabilityProf | MomentumMom | EPS revisionsRev | Market capMkt cap | P/EP/E | Revenue growthRev YoY | Div. yieldYield | Short % floatShort | Next earningsEarnings |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1TECHBio-Techne Corp | 4.50Strong Buy | B | C | A- | B- | A | $11.3B | 62.4 | -0.4% | — | 4.9% | Nov 4 |
| 2PGNYProgyny Inc | 4.50Strong Buy | A | — | B | A- | C- | $2.2B | 28.0 | — | — | 6.1% | Nov 4 |
| 3HQYHealthEquity Inc | 4.51Strong Buy | B | B | A | B- | C+ | $8.6B | 36.3 | +7.3% | — | 7.0% | Dec 2 |
| 4MDMednax Inc | 4.51Strong Buy | A+ | D+ | A | A | C- | $2.4B | 13.6 | +0.5% | — | — | — |
| 5LFSTLifestance Health Group Inc | 4.52Strong Buy | B+ | B+ | B+ | A+ | D | $5.1B | 101.0 | +20.4% | — | — | Nov 5 |
| 6AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | 4.53Strong Buy | — | B+ | B+ | A- | C | — | — | +9.3% | — | — | — |
| 7ARGXargenx NV ADR | 4.54Strong Buy | B | — | A | C+ | — | $56.4B | 43.6 | — | — | 2.2% | — |
| 8VCYTVeracyte Inc | 4.55Strong Buy | B+ | A- | A | A- | D- | $3.5B | 30.3 | +17.3% | — | — | Nov 4 |
| 9MCKMcKesson Corporation | 4.55Strong Buy | — | B- | B- | B+ | B+ | — | — | +8.8% | 0.40% | — | Nov 4 |
| 10HNGEHinge Health, Inc. | 4.56Strong Buy | B+ | — | A+ | A+ | F | $1.9B | 17.3 | — | — | — | — |
| 11OPCHOption Care Health Inc | 4.57Strong Buy | A | C | B | A | B- | $5.0B | 23.9 | +5.9% | — | 4.6% | Nov 4 |
| 12PHRPhreesia Inc | 4.58Strong Buy | A+ | A- | B | B- | C | $748M | 71.6 | +12.9% | — | 5.4% | Dec 14 |
| 13QGENQIAGEN N.V. | 4.58Strong Buy | — | C | A- | A- | — | — | — | +5.7% | — | — | Nov 4 |
| 14ZVRAZevra Therapeutics Inc. | 4.59Strong Buy | A- | A+ | A+ | C | D+ | $582M | 10.0 | +119.4% | — | — | — |
| 15THCTenet Healthcare Corporation | 4.60Strong Buy | — | C+ | A+ | B+ | B- | — | — | +5.4% | — | — | — |
| 16ENSGThe Ensign Group Inc | 4.61Strong Buy | A- | B | B | C | A | $10.2B | 27.0 | +18.9% | 0.16% | 2.5% | — |
| 17OPKOpko Health Inc | 4.61Strong Buy | B+ | F | A | A | A+ | $1.3B | 10.8 | -3.8% | — | 9.1% | Nov 4 |
| 18NHCNational HealthCare Corporation | 4.62Strong Buy | A | B- | A- | C+ | — | $3.2B | 23.0 | +6.9% | — | 6.1% | Nov 6 |
| 19WAYWaystar Holding Corp. Common Stock | 4.63Strong Buy | A- | B | A- | B | C+ | $5.5B | 40.9 | +19.2% | — | — | — |
| 20MDTMedtronic PLC | 4.64Strong Buy | A | C+ | A- | B+ | B- | $127B | 24.2 | +9.8% | 0.00% | 10.8% | Nov 17 |
| 21RPRXRoyalty Pharma Plc | 4.64Strong Buy | B+ | D+ | A | A | B- | $28.0B | 34.4 | +10.0% | — | 3.5% | Nov 4 |
| 22LLYEli Lilly and Company | 4.65Strong Buy | — | A | A+ | A+ | F | — | — | +45.5% | 0.56% | — | — |
| 23WSTWest Pharmaceutical Services Inc | 4.66Strong Buy | C+ | C+ | A- | A- | A- | $28.7B | 44.9 | +12.6% | — | 2.8% | — |
| 24ANIPANI Pharmaceuticals Inc | 4.67Strong Buy | A+ | A | A | D | C+ | $1.6B | 14.8 | +30.9% | — | 22.7% | Nov 5 |
| 25PCRXPacira BioSciences, Inc. | 4.67Strong Buy | A | D | B+ | A | B+ | $1.4B | 98.9 | +5.7% | — | — | Nov 5 |
Showing 25 of 68
Source: Lician Quant Grades (SEC EDGAR statements, EODHD prices and estimates); short interest: FINRA; earnings dates: earnings calendar; dividend yield: EODHD fundamentals · Quant run Nov 4, 2026
Grades rank each stock against its sector peers; they are not investment advice. How the rating and grades work · Short interest · Earnings calendar